These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27512705)

  • 1. Critical review of drug promotional literature using the World Health Organization guidelines.
    Ganashree P; Bhuvana K; Sarala N
    J Res Pharm Pract; 2016; 5(3):162-5. PubMed ID: 27512705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Appraisal of Drug Promotional Literature in Accordance With WHO Guidelines.
    Rode SB; Salankar HV; Katole NT; Deshkar AT; Dadmal AA; Parate SV
    Cureus; 2022 Aug; 14(8):e27644. PubMed ID: 36072198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Critical Review of the Drug Promotional Literature Published in Scientific Medical Journals and Available at Outpatient Departments: A Cross-Sectional Observational Study.
    Vivek K; Deolekar P; Naseem A; Langade DG; Yadav P
    Cureus; 2022 Nov; 14(11):e31283. PubMed ID: 36514598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West Nigeria.
    Fadare JO; Bankole I; Babatola A; Simeon Olatunya O; Aina F; Godman B
    Hosp Pharm; 2023 Feb; 58(1):62-69. PubMed ID: 36644744
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of rationality of promotional drug literature using World Health Organization guidelines.
    Mali SN; Dudhgaonkar S; Bachewar NP
    Indian J Pharmacol; 2010 Oct; 42(5):267-72. PubMed ID: 21206615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of drug promotional literatures published in scientific medical journals.
    Vachhani PM; Solanki MN; Desai MK
    J Pharm Bioallied Sci; 2016; 8(3):248-52. PubMed ID: 27413355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the reliability and accuracy of the promotional brochures for the generic pharmaceutical companies in Iraq using World Health Organization guidelines.
    Mikhael EM
    J Pharm Bioallied Sci; 2015; 7(1):65-8. PubMed ID: 25709340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical brochures in Lebanon: do they meet WHO recommendations?
    Fadoul Y; Haddad C; Habib J; Zoghbi M
    BMC Prim Care; 2022 Dec; 23(1):314. PubMed ID: 36474170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Analysis of Claims and Their Authenticity in Indian Drug Promotional Advertisements.
    Randhawa GK; Singh NR; Rai J; Kaur G; Kashyap R
    Adv Med; 2015; 2015():469147. PubMed ID: 26556557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of the validity of drug promotion materials in Ethiopia.
    Hailu HG; Gobezie MY; Yesuf TA; Workneh BD
    Drug Healthc Patient Saf; 2019; 11():47-54. PubMed ID: 31440103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Evaluation of Drug Advertisements in a Medical College in Lalitpur, Nepal.
    Jha N; Sapkota Y; Shankar PR
    J Multidiscip Healthc; 2020; 13():717-725. PubMed ID: 32801734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of promotional advertisements of drugs in a medical journal: an ethics perspective.
    Nath S; Bhowmick S; Dutta T; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sarkar M; Ram AK; Mukherjee PK
    Indian J Med Ethics; 2014; 11(4):237-41. PubMed ID: 25377037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of perceptions and exposure of drug promotional literature among clinicians in a teaching hospital.
    Sharma S; Akhoon N; Moe HW; Nair DR; Shashidhar V
    Perspect Clin Res; 2021; 12(3):140-145. PubMed ID: 34386378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information contents of drug advertisements: an Indian experience.
    Lal A
    Ann Pharmacother; 1998 Nov; 32(11):1234-8. PubMed ID: 9825093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic entry, reformulations and promotion of SSRIs in the US.
    Huskamp HA; Donohue JM; Koss C; Berndt ER; Frank RG
    Pharmacoeconomics; 2008; 26(7):603-16. PubMed ID: 18563951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribers Perception on Drug Promotional Literatures in A Tertiary Care Hospital in Nepal.
    Prasad P; Mudvari A; Ghimire R; Karki N; Yadav D; Shah S; Gyanwali P
    J Nepal Health Res Counc; 2021 Apr; 19(1):19-25. PubMed ID: 33934127
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.